# Biomedical Entrepreneurship Skills Development Program for the Advancement of Research Translation

> **NIH NIH R25** · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · 2020 · $102,586

## Abstract

Abstract:
This grant proposal describes a plan to design, implement and integrate within the NYU community an
educational program that teaches and trains students in Biomedical Entrepreneurship, with focus on the
commercialization of academic discoveries and inventions. The program builds upon the success of the
recently funded drug development educational program (NIDDK R25DK092170), developed and directed by
Drs. Gold-von Simson and Ramasamy, and aims to further expand the skill set of early stage scientists to
prepare them to actively participate in bed to bedside science translation. Through a variety of methods,
participants will gain an understanding of the requirements for launching and building a new venture in the
complex and highly regulated life sciences industry as well as the entrepreneurial journey of the scientist-
entrepreneur.
The program will focus on improving health innovations and developing effective solutions; this is at the core of
our mentored, entrepreneurial process. We will build upon the academic excellence at NYU with its track
record of success; two examples of successful collaborative discoveries at NYU led to the development of
disease altering therapies like Infliximab (Remicade) and Sunitinib (Sutent). Our program aims to promote
the commercial development of novel discoveries and breakthroughs, while leveraging early stage researchers
with innovative and creative ideas. The goal is to teach scientists and likeminded individuals at an early career
stage how to create solutions, whether at the molecular level or via the creation of medical devices or software
tools, to benefit those who suffer from disease. By introducing participants to the similarities and connections
between the pathogenesis mechanisms underlying diabetes and many metabolic diseases, and certain other
disease areas, we will enable and encourage them to think creatively about potential applications for their own
research from seemingly unrelated disease contexts such as autoimmunity and hyperimmunity, cancer, necro-
inflammatory diseases and others ultimately advancing the goals of the NIDDK and the NIH as a whole.
With the support of NIDDK, we can build a successful and self-sustaining biomedical entrepreneurship
educational program within the NYU and New York City community and provide career development support to
talented young scientists. With success of our program, we will share the curricula and methods with other US
academic centers, resulting in a positive and expeditious effect on the translation of science and medicine
nationally, a great mission of NIH.

## Key facts

- **NIH application ID:** 10017178
- **Project number:** 5R25DK119114-02
- **Recipient organization:** NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- **Principal Investigator:** Michal Gilon-Yanai
- **Activity code:** R25 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $102,586
- **Award type:** 5
- **Project period:** 2019-09-12 → 2024-07-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10017178

## Citation

> US National Institutes of Health, RePORTER application 10017178, Biomedical Entrepreneurship Skills Development Program for the Advancement of Research Translation (5R25DK119114-02). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/10017178. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*